Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Beta Drugs Ltd

NSE: BETA · BSE: 531481 · Pharmaceuticals & Biotechnology · 27 announcements

Share price
₹1,991.40
Market cap
₹2,208 Cr
Revenue (annual)
₹384.8 Cr
Net profit (annual)
₹41.48 Cr
P/E (TTM)
48.4×Sector 47.3×
Promoter holding
59.10%-5.53% QoQ
FII holding
1.02%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

18:01 IST NSE
Management Change

Beta Drugs Management Change

Beta Drugs Limited announced the re-appointment of its Statutory Auditor and an Executive Director. These re-appointments are effective from September 2026 and January 2027, respectively.